Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Sep 11;4(4):371–380. doi: 10.1016/j.bpsc.2018.08.014

Table 1.

Clinical and demographic characteristics of the participants.

Variable Control 1–2 Assaults 3+ Assaults
N 30 12 18

Age 15.35 (2.29) 16.20 (1.44) 16.26 (1.75)

IQ 117.34 (21.411)a 101.58 (18.913) 100.61 (19.011)a

Ethnicity
 White  60.0%  50.0%  61.1%
 Black  20.0%  33.3%  11.1%
 Asian  3.3%  0.0%  0.0%
 Hispanic, Latina  3.3%  8.3%  16.7%
 Pacific Islander  0.0%  0.0%  0.0%
 Native American  0.0%  0.0%  0.0%
 Other
 13.3%
 8.3%
 11.1%
Direct Assaults .00 (.00) 1.33 (.492)a 4.72 (1.447)a

% sexual assault 0.0% 66.7% 88.9%

% physical assault 0.0% 50.0% 88.9%

PTSD Diagnsosis % 0.0% 50.0% 55.6%

Mood Disorder % 0.0% 50.0% 50.0%

Anxiety Disorder % 0.0% 66.7% 72.2%

CAPS total severity n/a 39.42 (29.03) 45.28 (30.86)

UCLA PTSD RI n/a 27.17 (19.43) 30.72 (15.18)

CBCL Anxiety 2.30 (2.25)a, b 5.67 (6.08)a 10.17 (5.97)b

CBCL Depression 1.47 (1.89)a, b 4.92 (3.90)a 5.33 (2.99)b

Psychiatric Medications
 SSRI  0.0%  30.8%  38.9%
 SNRI  0.0%  7.7%  0%
 NDRI  0.0%  7.7%  0.0%
 Mood Stabilizer  0.0%  7.7%  16.7%
 Benzo  0.0%  7.7%  5.6%
 Stimulants  0.0%  15.4%  5.6%
 Other  0.0%  0.0%  5.6%

Note. Values represent means (SDs in parentheses) or percentages. Groups with matching superscripts were significantly different (p<.05). CAPS = Clinician Administered PTSD Scale. UCLA PTSD RI = UCLA PTSD Reaction Index. CBCL =Child-behavior checklist. Mood disorder includes major depressive disorder and bipolar disorder.